Skip to main content
TipRanks
Go Ultimate75% OFF

Grace Therapeutics (GRCE) Q4 2021 Earnings Report

1,210 Followers

GRCE Q4 2021 EPS Results

Actual EPS
-$1.44
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
$10.56

GRCE Q4 2021 Revenue Results

Actual Revenue
$115.00K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2021
Date
06/22/2021
Time
Before Open
Conference Call
Tuesday, June 22, 2021
GRCE Upcoming Earnings

Grace Therapeutics's next earnings date is estimated for February 15, 2027, based on past reporting schedules.

Q4 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

GRCE Earnings History

GRCE earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 15, 20272027 (Q3)-0.15--0.14――
Nov 12, 20262027 (Q2)-0.15-0.11-0.06-83.33% (-0.05)
Aug 13, 20262027 (Q1)-0.13-0.91-0.21-333.33% (-0.70)
Jun 18, 20262026 (Q4)-0.23-0.060.11-154.55% (-0.17)
Feb 12, 20262026 (Q3)-0.28-0.14-0.3661.11% (+0.22)
Nov 13, 20252026 (Q2)-0.25-0.06-0.380.00% (+0.24)
Aug 12, 20252026 (Q1)-0.22-0.21-0.2412.50% (+0.03)
Jun 23, 20252025 (Q4)-0.280.11-0.17164.71% (+0.28)
Feb 13, 20252025 (Q3)-0.34-0.36-0.21-71.43% (-0.15)
Nov 13, 20242025 (Q2)-0.37-0.30-0.4330.23% (+0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed